Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In a comprehensive review of 26 clinical trials involving nearly 15,500 participants, this peptide led to an average weight loss of up to 22% over 11 months, significantly outperforming the 14% weight loss observed with semaglutide (the active ingredient in Ozempic and Wegovy) over 15 months
10.1080/19382014.2019.1587976 76 PerryR
Lillys R&D pipeline now includes: Next-gen tirzepatide analogs : Lilly has analogues of tirzepatide (to extend patent life) and related peptides in clinical trials
June 22, 2026
US$ 26.51
US$ 25.95
US$ 20.50
US$ 20.57
US$ 23.79
US$ 28.76
US$ 20.71
US$ 20.05
US$ 27.72
US$ 29.56
